Kathleen Spring
Impact in
- Physiology top 1%
- Adenosine and Purinergic Signaling
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Galectins and Cancer Biology 5
-
- Angiogenesis and VEGF in Cancer 6
- Protein Tyrosine Phosphatases 5
- Co-authors
- Isabelle Royal (6 shared papers)John Stagg (4 shared papers)Sandra Pommey (3 shared papers)Martin Turcotte (2 shared papers)Matthieu Germain (1 shared paper)Giovanni Tosi (1 shared paper)Ruth Schmid (1 shared paper)Andreas Åslund (1 shared paper)
- Journals
- Cellular Signalling (2 papers)Blood (1 paper)Oncogene (1 paper)International Journal of Cancer (1 paper)Frontiers in Immunology (1 paper)
- Partner nations
- CanadaUnited StatesGermany
In The Last Decade
Kathleen Spring
14 papers receiving 894 citations
Peers
Comparison fields: 5 of 108
- Physiology 230
- Biomaterials 146
- Immunology 213
- Oncology 187
- Pharmaceutical Science 33
Countries citing papers authored by Kathleen Spring
This map shows the geographic impact of Kathleen Spring's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathleen Spring with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathleen Spring more than expected).
Fields of papers citing papers by Kathleen Spring
This network shows the impact of papers produced by Kathleen Spring. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathleen Spring. The network helps show where Kathleen Spring may publish in the future.
Co-authors
The 25 scholars most cited alongside Kathleen Spring, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 305 | |
| 2 | 2015 | 215 | |
| 3 | 2013 | 151 | |
| 4 | 2008 | 66 | |
| 5 | 2012 | 51 | |
| 6 | 2009 | 33 | |
| 7 | 2015 | 28 | |
| 8 | 2022 | 22 | |
| 9 | 2014 | 16 | |
| 10 | 2019 | 12 | |
| 11 | 2014 | 4 | |
| 12 | 2024 | 3 | |
| 13 | 2015 | 2 | |
| 14 | 2012 | 2 |
About Kathleen Spring
Kathleen Spring is a scholar working on Immunology, Molecular Biology, Information Systems, Physiology and Biomedical Engineering, having authored 14 papers that have together received 910 indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (6 papers), Galectins and Cancer Biology (5 papers), Protein Tyrosine Phosphatases (5 papers), Library Collection Development and Digital Resources (3 papers), Adenosine and Purinergic Signaling (3 papers), Library Science and Information Systems (2 papers), Peptidase Inhibition and Analysis (2 papers) and Research Data Management Practices (2 papers). The work is most often cited by research in Physiology (230 citations), Biomaterials (146 citations), Immunology (213 citations), Oncology (187 citations) and Pharmaceutical Science (33 citations). Kathleen Spring has collaborated with scholars based in Canada, United States and Germany. Frequent co-authors include Isabelle Royal, John Stagg, Sandra Pommey, Martin Turcotte, Matthieu Germain, Giovanni Tosi, Ruth Schmid, Andreas Åslund, Fanny Caputo and Raymond M. Schiffelers. Their work appears in journals such as Cellular Signalling, Blood, Oncogene, International Journal of Cancer and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.